AKT1 and gastric cancer: Erinacin A was also reported to have significant antitumor activity in human gastric cancer TSGH 9201 cells, in which it induced significant apoptosis associated with increased phosphorylation of focal adhesion kinase/protein kinase FAK/Akt/p70S6K and serine/threonine kinase PAK-1 pathways.